Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis

Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis

Abstract Background Recently, the addition of inhaled corticosteroid (ICS) to long-acting muscarinic antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy has been recommended for patients with COPD who have severe symptoms and a history of exacerbations because it reduces the ex...

Full description

Bibliographic Details
Main Authors: Akira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, Naoya Fujino, Tomotaka Kawayama, Hisatoshi Sugiura
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Respiratory Research
Subjects:
Chronic obstructive pulmonary disease
Exacerbations
Inhaled corticosteroid
Mortality
Pneumonia
Online Access:https://doi.org/10.1186/s12931-021-01777-x

Internet

https://doi.org/10.1186/s12931-021-01777-x

Similar Items